A director’s personal interest needs its own approval question

The signature does not answer every question

A director is asked to approve a company-data project and is also offered a personal benefit connected to it. The company may have an ordinary process for approving commercial work, but this circumstance raises another question: how must the director’s divided interest be addressed? A signature should not obscure that question.

UK official guidance separates duties concerning the company’s constitution, independent judgment, conflicts, third-party benefits and interests in a transaction. The Companies House page and Insolvency Service director hub were read on 16 October 2026. They are guidance for UK company directors, not a universal approval procedure for all employees, entities or jurisdictions.

A director may have corporate powers while still needing to address a duty concerning a personal interest. Conversely, an internal approval cannot supply missing rights to customer correspondence or contractor content. Keep corporate decision making, personal-interest review and source-rights evidence as separate layers.

An invented proposal with a personal benefit

Hypothetical example: Fictional Operating Company Ltd considers a GBP 10,000 data-license proposal. A fictional receiving party offers its director a GBP 2,000 personal benefit connected to that company transaction. No benefit has been accepted, no license executed and no source disclosure authorized. These amounts make the divided-interest facts concrete; they are not a VOID program, fee quote or earnings calculation.

Assume the company’s articles and relevant approval rules have not been examined. The archive’s source-rights review is also incomplete. The proposed director signature therefore cannot be treated as a completed answer to the benefit, company governance or source-permission questions.

The review needs the actual nature and recipient of the benefit, who offers it, why it is offered and the relationship to the proposed transaction. A vague line saying referral arrangement disclosed leaves too much hidden. A benefit offered personally to a director needs its own accurate description rather than being combined with money the company may receive.

Do not subtract GBP 2,000 from the company’s GBP 10,000 and call the remainder its earnings. The example has not established that either amount is payable, lawful or received, or that the benefit is an expense of the company. The useful result is a governance question with clear facts, not a financial optimization.

Declaration and permission are different steps

Companies House guidance tells directors to consider conflicts, disclose possible personal interests and follow the company’s constitution. It separately addresses third-party benefits. The Insolvency Service hub reinforces those duty categories and recommends professional advice when uncertain. Reading one disclosure sentence as automatic permission to accept a benefit would collapse different duties into one.

Give the responsible governance/legal reviewer the actual proposal, benefit details, relevant relationships, company articles and existing resolutions or delegations. Ask which duties and process apply, including who can participate in the decision and what evidence is needed. This article does not prescribe a quorum, recusal rule, statutory exception or method of authorizing the proposed benefit.

This article relies on official guidance. The complete current statutory provisions and exceptions concerning third-party benefits and transaction interests were not independently read, so it does not interpret them or clear a real arrangement. Obtain qualified advice where the actual legal effect needs resolution.

Return the right questions to the right owners

The completed hypothetical board-pack note would state the company proposal and personal-benefit facts, identify the governing documents still missing and ask for the appropriate independent governance/legal review before reliance on the director’s project approval. The record should distinguish a declared interest, a proposed process and a decision actually made. It should not retrospectively label the benefit approved.

Source rights remain with the relevant data and legal owners. If the company later resolves the governance question, that does not authorize disclosure of the archive or override a customer restriction. This article also makes no conclusion that an existing signature would be void; the effect of a real act and the director’s duties require their own analysis.

VOID’s possible conditional receiving-program compensation is disclosed separately from seller license proceeds, with no upfront seller referral fee. That company referral model does not establish or approve the invented personal benefit here. No introduction, payment or external message follows from this example. The company leaves with a defined review question, while the substantive approval remains with its proper authority.